Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

29
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
29
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

24
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
24
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

23
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
23
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

3.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

24
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
24

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Synbiotic Bactecal® reduces airway obstruction, sputum eosinophils and IL-4 but increases sputum IL-8 in patients with uncontrolled asthma" [Cytokine 202 (2026) 157145].

Cytokine·2026
Same author

Eccentric exercise training in multiple sclerosis management -a scoping review.

Multiple sclerosis and related disorders·2026
Same author

Synbiotic Bactecal® reduces airway obstruction, sputum eosinophils and IL-4 but increases sputum IL-8 in patients with uncontrolled asthma.

Cytokine·2026
Same author

Author Correction: Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective study.

Scientific reports·2026
Same author

Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective study.

Scientific reports·2025
Same author

Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users.

Journal of investigational allergology & clinical immunology·2025
Same journal

[Nature prescriptions and health promotion : sharing experience from primary care].

Revue medicale de Liege·2026
Same journal

[Eco-health: shared perspectives on primary care practice].

Revue medicale de Liege·2026
Same journal

[The strategic role of primary care in emerging diseases : surveillance, research, and preparedness].

Revue medicale de Liege·2026
Same journal

[Environmental impact of medicines and approaches for more eco responsible use].

Revue medicale de Liege·2026
Same journal

[Climate change and skin].

Revue medicale de Liege·2026
Same journal

[From Silent Spring to neuronal silence : pesticides and neurodegenerative diseases].

Revue medicale de Liege·2026
See all related articles

Related Experiment Video

Updated: Apr 25, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

10.7K

[Phenotypes in chronic obstructive pulmonary disease].

J-L Corhay, F Schleich, R Louis

    Revue Medicale De Liege
    |August 28, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Chronic Obstructive Pulmonary Disease (COPD) is a complex condition with diverse patient types. Understanding these COPD phenotypes is crucial for developing more personalized and effective treatment strategies.

    More Related Videos

    Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
    04:53

    Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

    Published on: October 18, 2024

    1.6K
    Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
    07:13

    Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

    Published on: January 6, 2015

    10.3K

    Related Experiment Videos

    Last Updated: Apr 25, 2026

    Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
    08:17

    Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

    Published on: August 25, 2017

    10.7K
    Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
    04:53

    Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

    Published on: October 18, 2024

    1.6K
    Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
    07:13

    Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

    Published on: January 6, 2015

    10.3K

    Area of Science:

    • Pulmonology
    • Genetics
    • Clinical Medicine

    Context:

    • Chronic Obstructive Pulmonary Disease (COPD) is recognized as a complex, multi-dimensional health condition.
    • Current GOLD guidelines for COPD diagnosis and treatment do not fully capture the disease's inherent heterogeneity.
    • Traditional COPD phenotypes include emphysema and chronic bronchitis, though many patients exhibit features of both.

    Purpose:

    • To highlight the heterogeneous nature of COPD.
    • To review and summarize existing data on various COPD phenotypes.
    • To emphasize the need for a more precise definition of COPD phenotypes.

    Summary:

    • COPD presents with multiple phenotypes beyond the traditional emphysema and chronic bronchitis classifications.
    • Factors such as genetics, clinical presentation, treatment response, and exacerbation frequency contribute to COPD heterogeneity.
    • Advanced analytical methods, like cluster analysis, are identifying novel COPD phenotypes.
    • Most patients present with overlapping features of emphysema and chronic bronchitis.

    Impact:

    • A precise definition of COPD phenotypes can facilitate a more targeted and individualized therapeutic approach.
    • Recognizing diverse COPD phenotypes may improve patient outcomes and treatment efficacy.
    • Further research into COPD phenotyping can refine clinical management strategies.